首页> 外文OA文献 >Impact of Chemotherapy Based Induction Using Dexamethasone, Cisplatin, Doxorubicin, Cyclophosphamide and Etoposide (DPACE) Versus Novel Agent Induction in Patients Undergoing Tandem Autologous Stem Cell Transplantation (ASCT) for Multiple Myeloma (MM)

【2h】

Impact of Chemotherapy Based Induction Using Dexamethasone, Cisplatin, Doxorubicin, Cyclophosphamide and Etoposide (DPACE) Versus Novel Agent Induction in Patients Undergoing Tandem Autologous Stem Cell Transplantation (ASCT) for Multiple Myeloma (MM)

机译：使用地塞米松，顺铂，多柔比星，环磷酰胺和依托磷脂（DAPACE）对多种骨髓瘤（MM）进行串联自体干细胞移植（ASCT）的新试剂诱导的影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Kalyan Nadiminti; Christopher Strouse; M Hasib Sidiqi; Lindsay Dozeman; Sarah L. Mott; Allyson Schultz; Jillna Claus; Praveen Vikas; Umar Farooq; Michael Tomasson; Margarida Silverman; Yogesh Jethava;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Carfilzomib-Lenalidomide-Dexamethasone (KRd) Induction-Autologous Transplant (ASCT)-Krd Consolidation Vs KRd 12 Cycles Vs Carfilzomib-Cyclophosphamide-Dexamethasone (KCd) Induction-ASCT-KCd Consolidation: Analysis of the Randomized Forte Trial in Newly Diagnosed Multiple Myeloma (NDMM) [J] . Gay Francesca, Cerrato Chiara, Scalabrini Delia Rota, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：Carfilzomib-lenalidomide-dexamethasone（KRD）感应 - 自体移植（ASCT）-KRD固结Vs KRD 12循环与CarfiLzomib-环磷酰胺 - 地塞米松（KCD）诱导-Sc-kCd固结：在新诊断的多发性骨髓瘤中的随机Forte试验分析（ NDMM）
2. Dexamethasone, cisplatin, doxorubicin, cyclophosphamide and etoposide (DPACE) is an effective salvage regimen for multiple myeloma refractory to novel agents [J] . RonchettiA.-M., IsnardF., BuffetM., Leukemia and lymphoma . 2013,第5期

机译：地塞米松，顺铂，阿霉素，环磷酰胺和依托泊苷（DPACE）是治疗难治性新型药物的多发性骨髓瘤的有效治疗方案
3. Bortezomib-thalidomide-dexamethasone versus bortezomib-cyclophosphamide-dexamethasone as induction therapy prior to autologous stem cell transplantation in multiple myeloma [J] . Moreau Philippe, Mary Jean-Yves, Attal Michel British Journal of Haematology . 2015,第Pta4期

机译：硼替佐米-沙利度胺-地塞米松与硼替佐米-环磷酰胺-地塞米松在多发性骨髓瘤自体干细胞移植前的诱导治疗
4. Phase 1 Trial of Retroviral-Mediated Transfer of the Human MDR-1 In Patients Undergoing High-Dose Chemotherapy and Autologous Stem Cell Transplantation [C] . Charles Hesdorffer, Janet Ayello, Maureen Ward, Keio International Symposium for Life Sciences and Medicine . 2000

机译：逆转录病毒介导的人MDR-1转移的第1期试验在接受高剂量化疗和自体干细胞移植的患者中
5. Cyclophosphamide thalidomide and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX randomized trial results [O] . Gareth J. Morgan, Faith E. Davies, Walter M. Gregory, 2012

机译：环磷酰胺沙利度胺和地塞米松作为新诊断为多发性骨髓瘤患者的自体干细胞移植的诱导疗法：MRC骨髓瘤IX随机试验结果
6. Double High Dose Salvage Therapy With Dose-Intensified Cyclophosphamide, Etoposide, and Cisplatin (DICEP) Re-Induction Followed by High-Dose Melphalan (HDM) and Autologous Stem Cell Transplantation (ASCT) Consolidation for Relapsed/Refractory Hodgkin Lymphoma [O] . Shafey M., Duan Q., Russell J.A., 2011

机译：双重大剂量挽救疗法，采用剂量增强的环磷酰胺，依托泊苷和顺铂（DICEP）再诱导，然后进行大剂量美法仑（HDM）和自体干细胞移植（ASCT）合并治疗复发/难治性霍奇金淋巴瘤

Impact of Chemotherapy Based Induction Using Dexamethasone, Cisplatin, Doxorubicin, Cyclophosphamide and Etoposide (DPACE) Versus Novel Agent Induction in Patients Undergoing Tandem Autologous Stem Cell Transplantation (ASCT) for Multiple Myeloma (MM)

著录项

相似文献

相关主题

期刊订阅